Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients

Autoimmunity Reviews
P ZaenkerM R Ziman

Abstract

A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Jul 14, 1995·Cell·N K Nanda, E E Sercarz
Apr 1, 1993·The Journal of Experimental Medicine·D GayM Weigert
Oct 31, 1998·Immunological Reviews·J A James, J B Harley
Jul 28, 2001·Trends in Immunology·V P TorchilinZ Estrov
Jul 28, 2001·Trends in Immunology·H A Doyle, M J Mamula
Aug 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·Senitiroh Hakomori
Nov 26, 2002·Immunological Reviews·Matthew J ScanlanYao-Tseng Chen
Jan 4, 2003·Nature Reviews. Immunology·Paul H Plotz
Jan 4, 2003·Nature Biotechnology·Sam Hanash
Jan 22, 2004·International Immunology·Elahna PaulMichael C Carroll
Aug 3, 2004·Nature Medicine·Bert Vogelstein, Kenneth W Kinzler
Oct 30, 2004·Current Opinion in Immunology·Stephen M Anderton
Nov 9, 2004·Current Opinion in Cell Biology·Aimee L Edinger, Craig B Thompson
Feb 9, 2005·International Journal of Cancer. Journal International Du Cancer·Susanne PreissThomas Blankenstein
Mar 1, 2005·Cancer Detection and Prevention·Félix Fernández MadridJohn E Tomkiel
Jun 3, 2005·Nature·Christopher C GoodnowCarola G Vinuesa
Jul 22, 2005·Nature Reviews. Cancer·Andrew J G SimpsonLloyd J Old
Aug 9, 2005·Journal of Proteome Research·Karen S Anderson, Joshua LaBaer
Sep 24, 2005·The New England Journal of Medicine·Xiaoju WangArul M Chinnaiyan
Jan 5, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vivian GoodellMary L Disis
Jan 7, 2006·Nature Reviews. Cancer·Karin E de VisserLisa M Coussens
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Catherine BarrowJonathan Cebon
Mar 10, 2007·Archivum Immunologiae Et Therapiae Experimentalis·Chuanlin Ding, Jun Yan
Mar 23, 2007·Molecular & Cellular Proteomics : MCP·Michel CaronRaymonde Joubert-Caron
Sep 15, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jeanette KaaeMads Melbye
Mar 28, 2008·Immunological Reviews·Eng M Tan, Jianying Zhang
Apr 9, 2008·Gastroenterology·Yvette SchwitalleMagnus von Knebel Doeberitz
Jun 30, 2009·Cancer Immunology, Immunotherapy : CII·Miriam ReuschenbachNicolas Wentzensen
Feb 17, 2010·Apoptosis : an International Journal on Programmed Cell Death·Christoph PeterKirsten Lauber
Mar 5, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karen S AndersonDaniel Cramer
Oct 28, 2010·Journal of Proteome Research·Karen S AndersonJoshua Labaer
May 9, 2012·International Journal of Radiation Oncology, Biology, Physics·Emily F StamellIsaac Brownell
Jun 12, 2012·International Journal of Cancer. Journal International Du Cancer·Pawel ZayakinAija Linē
Aug 9, 2012·Biomarker Insights·Tianhui LiuFederica Genovese
Nov 22, 2012·Oncoimmunology·Michael Linnebacher, Claudia Maletzki
Jun 8, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jie XiaHong Bu

❮ Previous
Next ❯

Citations

Jan 26, 2017·Lupus·G SinghA Singh
Jun 26, 2018·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Anastas PashovThomas Kieber-Emmons
Oct 3, 2018·Critical Reviews in Clinical Laboratory Sciences·Milena MusicEleftherios P Diamandis
Sep 18, 2018·Current Neuropharmacology·Hiroshi MitomaChristiane S Hampe
Jun 30, 2019·Cancers·Prachi GuptaSunila Pradeep
Jun 30, 2019·Clinical Proteomics·Milena MusicEleftherios P Diamandis
Sep 8, 2017·Open Biology·Sean Blandin KnightCaroline Dive
Oct 17, 2019·Cancer Immunology, Immunotherapy : CII·Yuki KasaharaChikashi Ishioka
Aug 11, 2018·Oncotarget·Pauline ZaenkerMel Ziman
Sep 25, 2017·Oncotarget·Shabarni GuptaSanjeeva Srivastava
Oct 22, 2018·The Cerebellum·Mario MantoChristiane S Hampe
Mar 7, 2020·Clinical & Translational Immunology·Vanessa M BeutgenFranz H Grus
Sep 26, 2017·Cerebellum & Ataxias·Hiroshi MitomaChristiane S Hampe
Mar 10, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Roberto VillaseñorLudovic Collin
Nov 22, 2017·International Journal of Cancer. Journal International Du Cancer·Renée T FortnerRudolf Kaaks
Sep 5, 2018·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Jessica Da Gama DuarteJonathan M Blackburn
Jul 18, 2018·Biosensors·Jingyi QiuTianfu Wu
Aug 28, 2019·Expert Review of Clinical Immunology·Fatemeh KiaeeAsghar Aghamohammadi
Oct 1, 2019·Journal of Veterinary Science·Kai Chung ChengAlbert Taiching Liao
Aug 11, 2018·Arthritis Research & Therapy·Zoe E BetteridgeJanine A Lamb
Aug 21, 2019·Oncoimmunology·Frank AntonyDaniele Sblattero
Aug 28, 2020·Frontiers in Cell and Developmental Biology·Xue-Jiao HanXia-Wei Wei
Jun 30, 2018·Journal of Translational Medicine·Hai-Min HwangEun-Wie Cho
Aug 24, 2019·Frontiers in Immunology·Michal A Rahat
Aug 26, 2017·Cancer Research·Kosei NakajimaAvraham Raz
Nov 17, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Amy L WilsonAndrew N Stephens
Sep 25, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William S ChenFelix Y Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.